The QJSB group exhibited lower levels of CYTC expression and reduced Caspase-3 activation compared to the CTX-treated group, indicating that QJSB may effectively regulate the mitochondrial pathway and prevent cell death in CD4+ T lymphocytes, ultimately improving leukopenia. Here, CD4 is linked to Decreased total leukocyte count.